Literature DB >> 12358631

How should hyperphosphatemia be managed in dialysis patients?

Geoffrey Block1, Jaime Uribarri, Joseph A Coladonato, Stanley L S Fan, John Cunningham, Charles R Nolan, Wajeh Y Qunibi, Jill S Lindberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12358631     DOI： 10.1046/j.1525-139x.2002.00077_1.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN： 0894-0959            Impact factor:   3.455


× No keyword cloud information.
  7 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2003

2.  Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients.

Authors:  Nazanin Noori; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Rachelle Bross; Debbie Benner; Joel D Kopple
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

3.  Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients.

Authors:  Emanuel Zitt; Claudia Lamina; Gisela Sturm; Florian Knoll; Friederike Lins; Otto Freistätter; Florian Kronenberg; Karl Lhotta; Ulrich Neyer
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-08       Impact factor: 8.237

Review 4.  Management of hyperphosphataemia in dialysis patients: role of phosphate binders in the elderly.

Authors:  Víctor Lorenzo Sellares; Armando Torres Ramírez
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?

Authors:  Christian S Shinaberger; Sander Greenland; Joel D Kopple; David Van Wyck; Rajnish Mehrotra; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

6.  Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels?

Authors:  Ruth Pepper; Neil Campbell; Magdi M Yaqoob; Norman B Roberts; Stanley L-S Fan
Journal:  BMC Nephrol       Date:  2011-10-12       Impact factor: 2.388

7.  Efficacy and safety of lanthanum carbonate on chronic kidney disease-mineral and bone disorder in dialysis patients: a systematic review.

Authors:  Chenglong Zhang; Ji Wen; Zi Li; Junming Fan
Journal:  BMC Nephrol       Date:  2013-10-17       Impact factor: 2.388
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.